Table 2.
Representative Lacritin cleavage sequences identified by MALDI-TOF
Fragment | *Amino Acid Sequence |
**Exp. M.W. [kDa] |
***Obs. M.W. [kDa] |
---|---|---|---|
1 | GEDASSDSTGADPAQEAGTSKPNEEISGPAEPASPPETTTTA QETSAAAVQGTAKVTSSRQELNPLKSIVEKSILLTEQALAKAG KGMHGGVPGGKQFIENGSEFAQKLLKKFSLLKPWAGLVPR |
12.84 | 12.96 |
2 | GEDASSDSTGADPAQEAGTSKPNEEISGPAEPASPPETTTTA QETSAAAVQGTAKVTSSRQELNPLKSIVEKSILLTEQALAKAG KGMHGGVPGGKQFIENGSEFAQKLLKKFSLLK |
11.84/ 11.97 |
12.00 |
3 | GEDASSDSTGADPAQEAGTSKPNEEISGPAEPASPPETTTTA QETSAAAVQGTAKVTSSRQELNPLKSIVEKSILLTEQALAKAG KGMHGGVPGGKQFIENGSEFAQKLLKK |
11.25/ 11.38 |
11.35/ 11.47/ 11.50 |
4 | PNEEISGPAEPASPPETTTTAQETSAAAVQGTAKVTSSRQEL NPLKSIVEKSILLTEQALAK |
6.42 | 6.36 |
Underlined sequence: Syndecan-1 binding site
Expected M.W. (kDa) for fragments were calculated by DNAStar Lasergene Editseq
Observed M.W. (kDa) was measured by MALDI-TOF